61.3 Chronic Tinnitus, Presbycusis & Persistent Dizziness

Chronic Tinnitus: Classification, Pathophysiology & Red Flags

Tinnitus is defined as the perception of sound (ringing, buzzing, hissing, whistling, humming, clicking, or roaring) in the absence of an external auditory stimulus. It is classified as chronic when it persists for $>3\text{ months}$. In the United States, chronic tinnitus affects approximately 10% to 15% of the adult population, with 20% to 25% of affected individuals experiencing clinically significant functional impairment, severe sleep disruption, anxiety, or depression.

Primary vs. Secondary Tinnitus

• Primary (Sensorineural) Tinnitus: Idiopathic, non-pulsatile, continuous tinnitus that is almost universally associated with underlying sensorineural hearing loss (SNHL). Cochlear hair cell loss (from presbycusis or noise trauma) diminishes afferent sensory input to the central auditory pathways. In response to this auditory deafferentation, the central nervous system undergoes maladaptive neuroplastic reorganization within the dorsal cochlear nucleus, inferior colliculus, and primary auditory cortex. The brain increases central neuronal gain, develops spontaneous synchronized hyperactivity, and establishes hyperconnectivity between the auditory cortex and the limbic system (amygdala, insula). This limbic involvement attaches emotional salience, autonomic distress, and vigilance to the phantom percept—analogous to phantom limb pain.
• Secondary Tinnitus: Tinnitus directly attributable to an identifiable underlying organic, mechanical, vascular, or structural otologic disorder (e.g., cerumen impaction, otitis media, otosclerosis, eustachian tube dysfunction, temporomandibular joint [TMJ] syndrome, vestibular schwannoma, or vascular malformations).

                  DIAGNOSTIC TRIAGE OF TINNITUS: LATERALITY & RHYTHMICITY

   Tinnitus Presentation       Underlying Pathophysiology               Mandatory Diagnostic Investigation
   ═══════════════════════════════════════════════════════════════════════════════════════════════════════════════
   Bilateral, Non-Pulsatile,   Cochlear hair cell degeneration          Comprehensive Audiometry;
   High-Pitched Ringing        (Presbycusis, chronic noise exposure)    No neuroimaging required if symmetric.
   ───────────────────────────────────────────────────────────────────────────────────────────────────────────
   UNILATERAL Non-Pulsatile    RED FLAG FOR RETROCOCHLEAR LESION:       BRAIN MRI with Internal Auditory Canal
   Tinnitus with Asymmetric    Vestibular Schwannoma (Acoustic Neuroma) (IAC) protocol WITH GADOLINIUM;
   Sensorineural Hearing Loss  compressing CN VIII in cerebellopontine   mandatory gold standard.
                               angle (CPA)
   ───────────────────────────────────────────────────────────────────────────────────────────────────────────
   PULSATILE Tinnitus          Vascular turbulent flow or elevated      CTA or MRA/MRV of Head and Neck;
   (Synchronous with pulse;    intracranial pressure: dAVF, carotid     Fundoscopic exam (papilledema);
   'whooshing' heartbeat sound) stenosis, glomus tumor, or IDIOPATHIC   Lumbar puncture for opening pressure
                               INTRACRANIAL HYPERTENSION (IIH)          (if IIH suspected).
   ═══════════════════════════════════════════════════════════════════════════════════════════════════════════════

High-Yield Red Flags in Tinnitus Evaluation

1. Unilateral Tinnitus with Asymmetric Sensorineural Hearing Loss:
   • Vestibular Schwannoma (Acoustic Neuroma): A benign, slow-growing Schwann cell neoplasm originating from the superior or inferior vestibular branch of the eighth cranial nerve (CN VIII) within the internal auditory canal and cerebellopontine angle.
   • Clinical Hallmarks: Progressive, unilateral high-frequency sensorineural hearing loss; unilateral non-pulsatile tinnitus; and poor speech discrimination (disproportionately impaired word recognition relative to pure-tone thresholds). Mild unsteadiness may occur, but true rotational vertigo is rare due to gradual central vestibular compensation.
   • Advanced Signs: Large tumors ($>2-3\text{ cm}$) compress adjacent structures: trigeminal nerve (CN V) causing ipsilateral facial hypesthesia or an absent corneal reflex; facial nerve (CN VII) causing mild facial paresis; cerebellum causing limb ataxia; and fourth ventricle compression causing hydrocephalus.
   • Diagnostic Gold Standard: Magnetic Resonance Imaging (MRI) of the Brain and Internal Auditory Canals (IACs) with thin-slice sequences and IV gadolinium contrast. High sensitivity can detect micro-schwannomas as small as 1 to 2 mm.
2. Pulsatile Tinnitus:
   • Tinnitus described as a rhythmic pulsing, clicking, or whooshing sound that matches the patient's arterial heartbeat is almost always secondary to an identifiable vascular or intracranial disorder:
     • Dural Arteriovenous Fistula (dAVF) or Arteriovenous Malformation (AVM): Abnormal direct arteriovenous shunts; carries a high risk of intracranial hemorrhage; requires CTA, MRA, or digital subtraction catheter angiography.
     • Carotid Artery Stenosis or Dissection: Turbulent arterial flow transmitted through the temporal petrous bone.
     • Paragangliomas (Glomus Tumors): Glomus tympanicum (middle ear) or Glomus jugulare (jugular bulb); hypervascular neuroendocrine tumors. Otoscopy classically reveals a pulsatile, reddish-blue retro-tympanic mass behind an intact tympanic membrane.
     • Idiopathic Intracranial Hypertension (IIH / Pseudotumor Cerebri): Elevated intracranial pressure transmitted to the dural venous sinuses produces turbulent venous flow, perceived as pulsatile tinnitus (see below).

Idiopathic Intracranial Hypertension (IIH)

• Epidemiology: Predominantly affects young, overweight or obese women of childbearing age (female-to-male ratio $8:1$; BMI $\ge 30\text{ kg/m}^2$).
• Clinical Presentation:
  • Holocephalic, daily, throbbing headache that worsens upon waking, recumbency, or Valsalva maneuvers (coughing, bending over).
  • Pulsatile tinnitus described as a 'washing machine' or rhythmic whooshing synchronous with the heartbeat.
  • Transient visual obscurations (TVOs): Brief episodes (lasting seconds) of partial or complete visual dimming or blackout, typically provoked by standing or bending.
  • Horizontal diplopia due to unilateral or bilateral abducens nerve (CN VI) palsy (a non-localizing false localizing sign caused by downward traction of the long intracranial course of CN VI across the petrous ridge).
• Physical Examination: Fundoscopy reveals bilateral papilledema (optic disc elevation, blurred margins, loss of physiological venous pulsations, flame hemorrhages).
• Diagnostic Protocol:
  1. Neuroimaging: Brain MRI with MR Venography (MRV) must precede lumbar puncture. Confirms absence of space-occupying lesions or cerebral venous sinus thrombosis. Classic neuroimaging findings of IIH include an empty sella turcica, flattening of the posterior sclera, distension of the perioptic subarachnoid space, and bilateral transverse venous sinus stenosis.
  2. Lumbar Puncture: Performed in the lateral decubitus position; demonstrates an elevated opening pressure $>250\text{ mm H}_2\text{O}$ ($>25\text{ cm H}_2\text{O}$) with completely normal CSF cytological and biochemical composition.
• Management:
  • Weight loss (a $5-10%$ reduction in total body weight is disease-modifying and induces remission).
  • Carbonic anhydrase inhibitors: Acetazolamide ($500-2000\text{ mg/day}$ in divided doses) reduces CSF production at the choroid plexus.
  • Second-line: Topiramate (promotes weight loss and has mild carbonic anhydrase activity).
  • Surgical Interventions: For progressive visual field loss refractory to medical therapy: optic nerve sheath fenestration (ONSF) to preserve vision, or CSF shunting (ventriculoperitoneal or lumboperitoneal shunt).

Evidence-Based Management of Primary Tinnitus

The American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) clinical practice guidelines emphasize an evidence-based approach:

• Comprehensive Audiometry: Mandatory initial test for all patients with persistent tinnitus to establish hearing thresholds and detect asymmetry.
• Bilateral Digital Hearing Aids: Recommended for patients with tinnitus accompanied by documented hearing loss. Amplification of ambient background environmental sounds elevates background acoustic input, masking the tinnitus signal and reducing central gain.
• Cognitive Behavioral Therapy (CBT): Highest level of clinical evidence (Grade A). While CBT does not reduce the physical decibel volume of tinnitus, it systematically restructures catastrophic cognitions, desensitizes limbic hyperarousal, improves coping mechanisms, and relieves associated insomnia and depression.
• Sound Masking & Sound Therapy: Desktop white-noise generators, wearable sound generators, or smartphone sound applications provide pleasant ambient masking sound to reduce the contrast between the tinnitus and quiet environments.
• Pharmacotherapy is NOT Recommended: Extensive clinical trials demonstrate that antidepressants, anticonvulsants (gabapentin), ginkgo biloba, zinc, melatonin, and transcranial magnetic stimulation provide no benefit over placebo. The AAO-HNS explicitly recommends AGAINST routine pharmacotherapy for primary tinnitus.

---

Presbycusis (Age-Related Hearing Loss)

Presbycusis is the most common sensory impairment in older adults, affecting over one-third of individuals aged 65 to 74 years and over half of those aged 75 and older. It represents a progressive, symmetrical, bilateral sensorineural hearing loss resulting from cumulative physiological aging, genetic susceptibility, environmental acoustic trauma, and microvascular strain.

                  SCHUKNECHT HISTOPATHOLOGICAL CLASSIFICATION OF PRESBYCUSIS

   Presbycusis Subtype       Primary Anatomical Site of Pathology       Audiometric Profile & Clinical Hallmark
   ═══════════════════════════════════════════════════════════════════════════════════════════════════════════════
   Sensory Presbycusis       Atrophy & loss of outer hair cells in      Steeply down-sloping high-frequency SNHL;
                             the BASAL TURN of the organ of Corti       speech discrimination preserved if quiet.
   ───────────────────────────────────────────────────────────────────────────────────────────────────────────
   Neural Presbycusis        Atrophy of cochlear spiral ganglion        Down-sloping high-frequency loss; DISPROPORTIONATE
                             neurons and auditory nerve fibers          loss of speech discrimination ('phonemic regression').
   ───────────────────────────────────────────────────────────────────────────────────────────────────────────
   Strial (Metabolic)        Atrophy of the STRIA VASCULARIS            FLAT sensorineural hearing loss across all
   Presbycusis               (loss of endolymph potential generation)   frequencies; excellent speech discrimination score.
   ───────────────────────────────────────────────────────────────────────────────────────────────────────────
   Cochlear Conductive       Stiffening & calcification of the          Gradually sloping high-frequency loss;
   (Mechanical)              basilar membrane of the cochlea            middle ear mechanics completely normal.
   ═══════════════════════════════════════════════════════════════════════════════════════════════════════════════

Clinical Manifestations

• Impaired Speech Understanding in Noise: The quintessential complaint is inability to understand spoken conversation in noisy, crowded acoustic environments—the 'cocktail party effect'.
• Loss of High-Frequency Consonants: The human ear relies on high frequencies ($2000-8000\text{ Hz}$) to distinguish voiceless consonant sounds (s, f, th, sh, p, t, k), while low frequencies ($250-1000\text{ Hz}$) convey vowel sounds (a, e, i, o, u). Because presbycusis primarily affects high frequencies, patients retain the volume of speech but lose clarity, complaining: "I can hear people talking, but I can't understand what they are saying" or "Everyone is mumbling."
• Recruitment: An abnormal, rapid increase in perceived loudness as sound intensity rises above the hearing threshold. A patient cannot hear normal conversation, but shouting is experienced as uncomfortably or painfully loud.
• Bilateral High-Pitched Tinnitus: Present in up to 70% of individuals with presbycusis.

Physical Examination & Tuning Fork Tests

• Otoscopy: The external auditory canals and tympanic membranes are completely normal; rules out cerumen impaction, tympanic membrane perforation, middle ear effusion, and otosclerosis.
• Weber Test (512 Hz Fork): Placed on the midline forehead or vertex; sound is perceived centrally in the midline (equal sensation in both ears), reflecting symmetric bilateral sensorineural loss.
• Rinne Test (512 Hz Fork): Tested on the mastoid process (bone conduction) and adjacent to the ear canal (air conduction); Air Conduction > Bone Conduction bilaterally (AC > BC; Positive Rinne). Confirms normal middle ear mechanics and rules out conductive hearing loss.

Diagnostic Audiometry

• Pure-Tone Air and Bone Conduction: Demonstrates a characteristic bilateral, symmetric, down-sloping sensorineural hearing loss that starts above $1000-2000\text{ Hz}$ and is most pronounced at $4000-8000\text{ Hz}$.
• No Air-Bone Gap: Bone conduction thresholds match air conduction thresholds (air-bone gap $\le 10\text{ dB}$).
• Tympanometry: Normal Type A curve (normal middle ear compliance and atmospheric pressure).

                  REPRESENTATIVE PURE-TONE AUDIOGRAM IN PRESBYCUSIS

   Frequency (Hz)  125    250    500    1000   2000   4000   8000
   Hearing Level
   -10 dB ───────────────────────────────────────────────────────── Normal Hearing Threshold
     0 dB
    10 dB
    20 dB ───────[Normal]────────────────────────────────────────── Hearing Loss Threshold
    30 dB ───────────────[Mild SNHL]──────────┐
    40 dB                                     │
    50 dB ────────────────────────────────────┴──[Moderate SNHL]──┐
    60 dB                                                         │
    70 dB ────────────────────────────────────────────────────────┴──[Severe SNHL]
    80 dB
    90 dB
   100 dB

   *Graph demonstrates classic down-sloping bilateral sensorineural loss sparing low frequencies (250-1000 Hz)
    with progressive, severe loss at high frequencies (4000-8000 Hz) responsible for consonant clarity.

Systemic & Cognitive Implications

Untreated hearing loss is not an isolated sensory deficit. It fosters social isolation, communication breakdown, loss of autonomy, and late-life depression. The landmark Lancet Commission on Dementia Prevention identified mid-life and late-life hearing loss as the single largest modifiable risk factor for dementia, accounting for 8% of all dementia cases worldwide. Cognitive load theory suggests that excessive mental effort spent decoding degraded acoustic signals depletes cognitive reserves required for working memory and executive function.

Clinical Management

1. Bilateral Digital Hearing Aids: The primary treatment modality. Modern programmable digital aids utilize multi-channel compression to selectively amplify high-frequency sounds without uncomfortably amplifying lower frequencies.
2. Over-The-Counter (OTC) Hearing Aids: FDA-regulated direct-to-consumer devices for adults aged $\ge 18\text{ years}$ with perceived mild-to-moderate hearing impairment; greatly increases accessibility and affordability.
3. Assistive Listening Devices: Remote wireless FM microphones, television streaming adapters, pocket talkers, and amplified telephones.
4. Communication Tactics: Advise family members to face the patient directly in well-lit rooms, gain attention before speaking, eliminate background television or radio noise, and articulate clearly at a natural volume without shouting.
5. Cochlear Implantation: Indicated for older adults with severe-to-profound bilateral sensorineural loss who achieve $<50-60%$ word recognition scores despite optimal digital hearing aids.

---

Persistent Postural-Perceptual Dizziness (PPPD)

Persistent Postural-Perceptual Dizziness (PPPD) is a chronic functional vestibular and neurological disorder recognized by the Bárány Society and the World Health Organization (ICD-11). It is the most common cause of chronic, persistent dizziness in adults aged 20 to 50 years, accounting for 15% to 20% of patients presenting to specialized vestibular centers.

Pathophysiology

PPPD represents a failure of the brain's postural control system to adapt following an acute vestibular or balance disturbance:

• The Precipitating Event: An acute medical, neurological, or vestibular event (e.g., Benign Paroxysmal Positional Vertigo [BPPV], vestibular neuritis, Meniere disease, concussion, panic attack, or vasovagal syncope) triggers an acute mismatch in sensory inputs.
• Maladaptive Neuro-Vestibular Processing: In a healthy individual, normal multimodality integration (visual, vestibular, and proprioceptive) is restored once the acute trigger resolves. In patients who develop PPPD, the central nervous system adopts three chronic maladaptive compensatory mechanisms:
  1. Visual Dependence: The brain becomes pathologically over-reliant on visual cues for spatial orientation while discounting vestibular and somatosensory inputs.
  2. High-Gain Postural Stiffening: Pathological co-contraction of axial and lower-extremity postural muscles with continuous postural hypervigilance.
  3. Failure of Habituation: Inability of central cortical networks to filter out ambient environmental motion or self-generated motion cues.

Bárány Society Diagnostic Criteria for PPPD

All five of the following clinical criteria must be fulfilled to establish the diagnosis:

1. Core Symptoms: One or more symptoms of non-spinning dizziness, unsteadiness, or a sensation of rocking/swaying present on most days for $\ge 3\text{ months}$.
2. Temporal Pattern: Symptoms persist for prolonged periods (hours at a time), waxing and waning in severity throughout the day.
3. Three Exacerbating Factors: Symptoms are exacerbated by:
   • Upright posture (standing or walking).
   • Active or passive motion (head movements, walking, riding in a vehicle).
   • Complex or moving visual environments (walking through busy supermarkets, crowded shopping malls, viewing moving traffic, watching action movies, or scrolling on a computer screen).
4. Precipitating Trigger: The condition is precipitated by an acute balance disorder, neurological illness, or psychiatric event.
5. Functional Impairment: Symptoms cause clinically significant distress or impairment, and are not better accounted for by another medical or psychiatric disease.

Diagnostic Evaluation & Findings

• Physical & Neurological Examination: Completely NORMAL. Cranial nerves, motor strength, cerebellar testing (finger-to-nose, heel-to-shin, rapid alternating movements), sensory testing, and standard gait examination are entirely unremarkable.
• Vestibular & Neuroimaging Testing: Caloric testing, videonystagmography (VNG), rotary chair, and Brain MRI are normal (or demonstrate only a well-compensated, fully resolved prior peripheral vestibular deficit).

Multimodal Management Paradigm

• Patient Education & Validation: The essential first step is communicating that PPPD is a legitimate, recognized neurobiological disorder representing a functional 'software' recalibration failure of central balance pathways rather than structural 'hardware' brain damage.
• Vestibular Rehabilitation Therapy (VRT): Highly effective; customized desensitization exercises, optokinetic visual stimulation, and balance challenges designed to habituate motion sensitivity and decouple visual dependence.
• Pharmacotherapy: SSRIs (e.g., Sertraline 25-50 mg daily, Escitalopram 10 mg daily) or SNRIs (e.g., Venlafaxine XR 37.5-75 mg daily) are first-line agents. They modulate central serotonergic pathways in the vestibular nuclei and anxiety circuits, reducing motion sensitivity. They should be continued for at least 6 to 12 months.
• Cognitive Behavioral Therapy (CBT): Targets hypervigilance, health anxiety, and avoidance behaviors (such as avoiding grocery stores).
• STRICT CONTRAINDICATION: Chronic vestibular suppressants (meclizine, dimenhydrinate, benzodiazepines) are strictly contraindicated. They blunt central neuroplastic compensation, impair vestibular recalibration, and exacerbate the chronicity of PPPD.

---

Clinical Contrast: Benign Paroxysmal Positional Vertigo (BPPV)

Benign Paroxysmal Positional Vertigo (BPPV) is the most common cause of acute, recurrent peripheral vertigo, accounting for up to 50% of peripheral vestibular complaints.

                  COMPARATIVE MATRIX: PPPD VS. BPPV

   Feature                  Persistent Postural-Perceptual Dizziness (PPPD)   Benign Paroxysmal Positional Vertigo (BPPV)
   ═══════════════════════════════════════════════════════════════════════════════════════════════════════════════════
   Pathophysiology          Functional central balance recalibration          Canalithiasis: free-floating otoconia in
                            failure; visual dependence & postural stiffening   semicircular canal (posterior canal in >85%)
   ───────────────────────────────────────────────────────────────────────────────────────────────────────────
   Nature of Symptoms       Non-spinning dizziness, swaying, rocking,         VIOLENT ROTATIONAL SPINNING VERTIGO;
                            unsteadiness, feeling 'on a boat'                 nausea, oscillopsia
   ───────────────────────────────────────────────────────────────────────────────────────────────────────────
   Duration of Episodes     Continuous / fluctuating for HOURS on most        BRIEF: strictly lasts < 60 SECONDS per episode
                            days for >= 3 months
   ───────────────────────────────────────────────────────────────────────────────────────────────────────────
   Provoking Factors        Upright posture, motion, complex visual           SPECIFIC HEAD POSITION CHANGES relative to
                            stimuli (supermarkets, scrolling screens)         gravity (rolling over in bed, looking up/down)
   ───────────────────────────────────────────────────────────────────────────────────────────────────────────
   Diagnostic Maneuver      Dix-Hallpike is NEGATIVE; exam is normal          DIX-HALLPIKE TEST POSITIVE: latency (2-10s),
                                                                              torsional upbeat geotropic nystagmus (<60s)
   ───────────────────────────────────────────────────────────────────────────────────────────────────────────
   Definitive Treatment     Vestibular rehabilitation therapy (VRT),          EPLEY MANEUVER (Canalith Repositioning);
                            SSRIs/SNRIs, and Cognitive Behavioral Therapy     >85-90% cure rate in 1-2 sessions;
                            (Meclizine is CONTRAINDICATED)                    (Meclizine has NO ROLE)
   ═══════════════════════════════════════════════════════════════════════════════════════════════════════════════

Pathophysiology & Diagnosis of BPPV

• Canalithiasis: Otoconia (calcium carbonate crystals) detach from the otolithic membrane of the utricle and migrate into a semicircular canal—most commonly the posterior semicircular canal ($>85-90%$ of cases). When the head moves relative to gravity, the heavy otoconia move within the canal, creating hydrodynamic drag on the endolymph that deflects the cupula and triggers intense, false rotational signals.
• The Dix-Hallpike Maneuver: The definitive diagnostic gold standard for posterior canal BPPV:
  1. The patient sits upright on the examination table with the head turned $45^\circ$ toward the ear being tested.
  2. The patient is rapidly moved to the supine position with the head extending $20^\circ$ below the table edge while maintaining the $45^\circ$ head turn.
  3. Positive Test Criteria:
     • Latency Period: 2 to 10 seconds elapse before vertigo and nystagmus begin.
     • Classic Nystagmus: A paroxysmal, crescendo-decrescendo torsional (rotational) and upbeat geotropic nystagmus (the upper pole of the eye beats toward the dependent ground and forehead).
     • Duration: The vertigo and nystagmus fatigue and resolve in $<60\text{ seconds}$.
     • Fatigability: Immediate repetition of the maneuver produces diminished vertigo and nystagmus.

Definitive Management: The Epley Maneuver

Posterior canal BPPV is treated mechanically with the Epley maneuver (Canalith Repositioning Procedure):

• A 4-step sequence of head positions ($45^\circ$ head turn supine $\rightarrow$ head rotated $90^\circ$ to contralateral side $\rightarrow$ patient rolls onto shoulder with head turned $45^\circ$ toward the floor $\rightarrow$ patient returned to upright sitting).
• Each position is held for 30 to 60 seconds (or until nystagmus ceases). Gravity guides the otoconia out of the posterior semicircular canal back into the utricle, where they are reabsorbed by dark cells.
• Efficacy: The Epley maneuver cures posterior canal BPPV in $>85%$ to 90% of patients after 1 to 2 sessions. Routine vestibular suppressants (meclizine) have no role and should not be prescribed.